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Abstract
Background: In vivo proton magnetic resonance spectroscopy (1H-MRS) studies of HIV-infected
humans have demonstrated significant metabolic abnormalities that vary by brain region, but the
causes are poorly understood. Metabolic changes in the frontal cortex, basal ganglia and white
matter in 18 SIV-infected macaques were investigated using MRS during the first month of infection.
Results: Changes in the N-acetylaspartate (NAA), choline (Cho), myo-inositol (MI), creatine (Cr)
and glutamine/glutamate (Glx) resonances were quantified both in absolute terms and relative to
the creatine resonance. Most abnormalities were observed at the time of peak viremia, 2 weeks
post infection (wpi). At that time point, significant decreases in NAA and NAA/Cr, reflecting
neuronal injury, were observed only in the frontal cortex. Cr was significantly elevated only in the
white matter. Changes in Cho and Cho/Cr were similar across the brain regions, increasing at 2
wpi, and falling below baseline levels at 4 wpi. MI and MI/Cr levels were increased across all brain
regions.
Conclusion: These data best support the hypothesis that different brain regions have variable
intrinsic vulnerabilities to neuronal injury caused by the AIDS virus.
Background
Despite the successes of antiretroviral therapies, the neu-
rocognitive complications of AIDS infection (neuroAIDS)
continue to be an important problem [1]. Interestingly,
clinical, neuropathological and imaging studies have
demonstrated that the virus variably affects different
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regions of the brain [2-4]. In vivo 1H MRS studies of chron-
ically HIV infected patients have disclosed varying meta-
bolic abnormalities in different brain regions [5,6]. Some
have reported that the most profound MRS changes occur
in the basal ganglia and white matter [7,8] while others
have reported significant changes in the frontal cortex of
HIV patients, even in patients free of neurological symp-
toms [9].
The simian immunodeficiency virus (SIV)-infected rhesus
macaque model is arguably the best animal model of neu-
roAIDS [10]. There are strong neuropathological similari-
ties between HIV patients and SIV-infected macaques
[11,12]. In vivo macaque brain 1H MR spectra are similar
to humans and post mortem and in vivo MRS studies from
SIV infected macaques have revealed metabolic abnor-
malities [13-15] similar to those observed in HIV-infected
human brains by in vivo MRS [16,17]. A power calculation
conducted by Greco et al. revealed that single voxel MRS
at 1.5 Tesla was capable of detecting changes similar to
those observed in human MRS studies for most metabo-
lites using less than 10 animals [18].
Eight of the animals reported on in this study were
allowed to progress until terminal AIDS or the 2 year end-
point of the study. Pathology of the harvested brains
revealed that two out of the eight animals developed SIVE
encephalitis (SIVE) as defined by the presence of perivas-
cular infiltrates of macrophages and multinucleated giant
cells [19]. These findings are consistent with previous
reports that neuropathological changes are variable, with
SIV encephalitis developing in 25% of infected macaques
[20] similar to the incidence of encephalitis in HIV-
infected humans. Furthermore, spectroscopy on these ani-
mals revealed that an elevation of basal ganglia Cho/Cr at
four weeks post-inoculation is predictive for the develop-
ment of SIV encephalitis [19].
The objective of our study was to evaluate macaque brain
regional variations during acute SIV infection. During the
first month of SIV infection, very rapid changes in macaque
blood viral load are observed [21] much like its human
counterpart. We previously reported that profound meta-
bolic changes occur in the frontal cortex of macaques in the
first weeks after SIV infection [15]. To help understand
brain region specific variations in HIV/AIDS, we evaluated
the neurochemical changes observed by in vivo 1H MRS in
the basal ganglia and white matter, and compared them to
the changes seen in the frontal cortex in 18 SIV-infected
rhesus macaques. This study aims to reveal which brain
regions are more susceptible to gliosis and neuronal injury
during the primary phase of infection.
Results
A total of 18 rhesus macaques were infected with SIV, and
imaged with in vivo 1H MRS at multiple time points
including pre-infection and up to 4 weeks after infection.
1H MR spectra were separately acquired from 3 specific
brain regions, frontal cortex, basal ganglia, and centrum
semiovale, as illustrated in Figure 1. 1H MR spectra with
short echo time (TE = 35 ms) are characterized by reso-
nances primarily arising from NAA, MI, Cr, Cho, and Glx
(Figure 1). Peak viremia was observed at ~11–12 days pi
(dpi) with a mean plasma level of 5.8 × 107 copy eq./mL.
At 4 wpi, the mean plasma viral load was 4.0 × 106 copy
eq./mL
A multivariate analysis of variance (MANOVA) was per-
formed for all metabolites across all time points and brain
regions, and highly significant differences were found (P
< 0.0001). Further analyses isolated temporal (P <
0.0001) and regional differences (P = 0.007). Below, we
detail the temporal metabolic changes during the first 4
weeks of SIV infection, and the metabolic changes that
occur in different brain regions.
Temporal changes in metabolite concentrations during 
acute SIV infection
The normalized changes in the mean concentrations of NAA,
Cr, Cho, MI, and Glx after infection in each brain region are
graphically displayed in Figure 2. Metabolite concentrations
(average levels ± SEM) and the results of the statistical analy-
ses are listed in Table 1. P-values were obtained using
repeated measures analysis of variance (RM ANOVA) on 12
animals measured before infection and at 2 and 4 wpi. If sig-
nificant by RM ANOVA, Holm's t-tests were used to isolate
differences between the time points. Additionally, paired t-
tests were performed on all 18 animals scanned before infec-
tion and 2 wpi. NS indicated that ANOVA or t-tests were not
significant. The most significant changes were observed in
the frontal cortex and were consistent with previous studies
[15]. NAA is significantly decreased at 2 wpi but is not differ-
ent from baseline at 4 weeks. Cho shows a trend towards
increase at 2 wpi (P = 0.077) but falls below baseline levels
at 4 wpi. MI increases at 2 wpi and remains elevated. Cr con-
centration did not change over time in the frontal cortex.
Thus, changes in metabolite concentration and metabolite
ratios with respect to Cr are similar. No change in frontal Glx
was identified.
Interestingly, we found a significant increase in the Cr
concentration at 2 wpi in the white matter of the centrum
semiovale. Similar to the frontal cortex, white matter Cho
increases significantly at the time of peak viremia at 2 wpi
and decreases to a level below baseline at 4 weeks. Like-
wise, MI increases at 2 weeks and stays elevated at 4 weeks.
However, NAA concentrations in the centrum semiovale
show no significant differences during the first month of
infection. A significant decrease in the white matter NAA/
Cr (7.5% decline, P = 0.022) at 2 weeks is explained by an
increase in Cr at that time point. Again, no significant Glx
changes could be detected.BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
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In the basal ganglia, absolute metabolite concentration
changes over time were not statistically significant. How-
ever, while the Cho concentration did not change signifi-
cantly at any time point after infection, Cho/Cr ratio did
show a significant decline of 8.9% (P = 0.011) between 2
and 4 wpi. Inspection of the absolute concentration val-
ues of these 2 metabolites suggests that the change in the
ratio is driven primarily by a decline in Cho, and the lower
variances observed in ratios accounts for the observation
of the statistically significant decline. Notably, a decline in
Cho/Cr between 2 and 4 wpi was also observed in the
frontal cortex (19.6% decline, P < 0.0001) and the white
matter (10.5% decline, P = 0.019). Basal ganglia NAA and
Glx changes after infection were not significant. If present,
they are within the experimental error of the measure-
ments.
Voxel locations (left) and corresponding representative spectra are shown for the frontal cortex (top), basal ganglia (middle),  and white matter of the centrum semiovale (bottom) Figure 1
Voxel locations (left) and corresponding representative spectra are shown for the frontal cortex (top), basal 
ganglia (middle), and white matter of the centrum semiovale (bottom). The major metabolites are labeled on the 
spectra, as well as dashed lines corresponding to pre-infection levels. Spectra are from a single representative animal, are not 
baseline corrected or apodized. Top: Frontal cortex MR spectra of a representative monkey before infection, at 2 and 4 wpi. 
Spectra are scaled to the creatine resonance because Cr levels did not change in frontal cortex during acute SIV infection. It 
can be seen from the spectra that NAA is decreased at 2, Cho is decreased at 4 wpi, and MI is increased at 2 and 4 wpi. (Due 
to the difficulty in finding spectra from a single animal that are representative of the group data in all aspects, we would like to 
note that the decrease in NAA at 4 wpi is not representative of the unchanged NAA concentration reflected in the group 
data). Middle: Basal ganglia MR spectra are scaled to the Cr peak as the Cr concentration did not change. No significant 
changes in NAA were observed. A decrease in Cho is evident by 4 wpi. Finally, an increase in MI can be observed from at 2 and 
4 wpi. Bottom: White Matter MR spectra of a the same representative monkey before infection, at 2 and 4 wpi. Spectra are 
scaled to the NAA resonance because NAA levels did not change in white matter semiovale during acute SIV infection. It can 
be seen from the spectra that Cr is increased at 2 wpi, and Cho is increased and then decreased to baseline levels at 4 wpi. An 
increase in MI can also be detected.
MI
Cho
Cr
NAA
Glx
4321 1 1 22 33 4 4
1H Chemical Shift (ppm) 1H Chemical Shift (ppm) 1H Chemical Shift (ppm)
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Correlations between metabolite concentration changes in 
different regions
To determine whether metabolic markers, NAA, Cho, MI,
Cr and Glx levels change in a similar fashion during acute
SIV infection in the frontal cortex, white matter and basal
ganglia, Spearman Rank correlation analyses were under-
taken. Table 2 summarizes the correlations between
metabolite concentration changes in different regions.
The rationale for correlating the changes of metabolites in
different brain regions was to determine if the metabolic
responses were uniform throughout the brain or if some
regions are affected to a greater extent. We interpret posi-
tive correlations to mean that the responses to infection
are similar in different brain regions, and that the
responses are different when they do not correlate.
No significant correlations between NAA concentration
changes in the frontal cortex and white matter, and
between frontal cortex and basal ganglia NAA were found.
While no significant temporal changes in NAA were found
in the basal ganglia or white matter, Spearman Rank anal-
ysis revealed a significant association between white mat-
ter and basal ganglia changes (P = 0.0049, Rs = 0.50). For
the choline changes, Spearman Rank analyses revealed
Table 1: Average levels ± SEM of measured absolute metabolites in institutional units for NAA, Glx, Cr, Cho and MI in SIV infected 
macaques analyzed by in vivo MR spectroscopy
Frontal Cortex White Matter Basal Ganglia
NAA Uninfected 6.86 ± 0.19 7.94 ± 0.24 7.38 ± 0.15
2 wpi 6.26 ± 0.15 7.82 ± 0.13 7.17 ± 0.16
4 wpi 6.83 ± 0.79 7.92 ± 0.65 7.22 ± 0.68
RM ANOVA P = 0.025 NS NS
Holm't t-test pre – 2 wpi. P = 0.011
Holm's t-test pre – 4 wpi NS
Holm's t-test 2 wpi – 4 wpi P = 0.035
Paired t-test pre – 2 wpi P = 0.021 NS NS
Glx Uninfected 12.30 ± 0.26 11.71 ± 0.32 11.96 ± 0.23
2 wpi 11.81 ± 0.29 11.14 ± 0.38 11.07 ± 0.29
4 wpi 12.80 ± 0.29 11.26 ± 0.31 12.03 ± 0.30
RM ANOVA NS NS NS
Holm't t-test pre – 2 wpi
Holm's t-test pre – 4 wpi
Holm's t-test 2 wpi – 4 wpi
Paired t-test pre – 2 wpi NS NS P = 0.052
Cr Uninfected 5.60 ± 0.09 5.76 ± 0.14 6.65 ± 0.10
2 wpi 5.450 ± 0.13 6.15 ± 0.13 6.49 ± 0.08
4 wpi 5.78 ± 0.10 6.01 ± 0.18 6.53 ± 0.14
RM ANOVA NS P = 0.025 NS
Holm't t-test pre – 2 wpi P = 0.007
Holm's t-test pre – 4 wpi NS
Holm's t-test 2 wpi – 4 wpi NS
Paired t-test pre – 2 wpi NS P = 0.003 NS
Cho Uninfected 1.014 ± 0.03 0.9754 ± 0.04 1.18 ± 0.03
2 wpi 1.066 ± 0.025 1.078 ± 0.05 1.20 ± 0.04
4 wpi 0.91 ± 0.04 0.9334 ± 0.04 1.10 ± 0.06
RM ANOVA P < 0.0001 P = 0.007 NS
Holm't t-test pre – 2 wpi P = 0.077 P = 0.008
Holm's t-test pre – 4 wpi P = 0.016 NS
Holm's t-test 2 wpi – 4 wpi P < 0.0001 P = 0.004
Paired t-test pre – 2 wpi NS NS NS
MI Uninfected 5.25 ± 0.14 4.72 ± 0.18 5.06 ± 0.12
2 wpi 5.81 ± 0.08 5.15 ± 0.13 5.21 ± 0.15
4 wpi 5.98 ± 0.23 5.45 ± 0.23 5.45 ± 0.18
RM ANOVA P = 0.048 P = 0.033 NS
Holm't t-test pre – 2 wpi P = 0.080 P = 0.051
Holm's t-test pre – 4 wpi P = 0.018 P = 0.013
Holm's t-test 2 wpi – 4 wpi NS NS
Paired t-test pre – 2 wpi P = 0.003 P = 0.029 NS
P-values were obtained using repeated measures analysis of variance (RM ANOVA) on 12 animals measured before infection and at 2 and 4 wpi. If 
significant by RM ANOVA, Holm's t-tests were used to isolate differences between the time points. Additionally, paired t-tests were performed on 
all 18 animals scanned before infection and 2 wpi. NS indicated that ANOVA or t-tests were not significant.BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
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Temporal spectroscopic changes observed in the normalized absolute concentrations of Cr, Cho, MI, NAA, and Glx in SIV- infected rhesus macaques measured in the frontal cortex (FC), white matter (WM) and basal ganglia (BG) Figure 2
Temporal spectroscopic changes observed in the normalized absolute concentrations of Cr, Cho, MI, NAA, 
and Glx in SIV-infected rhesus macaques measured in the frontal cortex (FC), white matter (WM) and basal 
ganglia (BG). Statistics are given in Table 1.
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correlations between all three brain regions (frontal cortex
vs. white matter P = 0.0032, Rs = 0.52; frontal cortex vs.
basal ganglia P = 0.052, Rs = 0.36 and white matter vs.
basal ganglia P = 0.0021, Rs = 0.54). MI changes were cor-
related between frontal cortex and basal ganglia (P =
0.043, Rs = 0.37), but not between white matter and the
other two regions. There was no significant correlation
between Cr concentration changes in the three brain
regions. Finally, Glx changes were correlated between
frontal cortex and basal ganglia (P = 0.0034, Rs = 0.05),
but, no correlation was found between white matter and
basal ganglia. A trend was found between Glx changes in
the frontal cortex and white matter.
Correlations between metabolite concentration changes 
and plasma viral loads
We also investigated correlations between plasma viral
load and metabolite concentration changes in the 3 vol-
umes of interest (VOIs). Viral load data was obtained
from 8 animals at 2 and/or 4 wpi for a total of 10 data
points. Using Spearman Rank, we found a significant cor-
relation between the change in the Cho/Cr ratio in the
frontal cortex and change in the plasma viral loads at 2
and 4 weeks combined (Rs = 0.67, P = 0.035). In addition,
we found a correlation between plasma viral loads and
Cho/Cr changes in the basal ganglia (Rs = 0.70, P = 0.009)
and Cho changes in BG (Rs = 0.77, P = 0.02). There was no
relationship between WM changes and plasma viral loads.
Furthermore, there was no relationship between any of
the other metabolite concentrations/ratios and viral
loads. However, due to the small sample size, we consider
these analyses highly preliminary.
Discussion
A long-standing observation in patients infected with HIV
is that different parts of the brain appear to be variably
affected by the virus. Evidence for variable response to the
virus by different brain regions has come from clinical,
pathological and imaging studies. To help gain a better
understanding of this phenomenon, we used in vivo 1H
MR spectroscopy to probe how different regions of the
macaque brain respond metabolically during the first
month of SIV infection, a time point not normally acces-
sible by clinical studies. At the time of peak viremia, a
transient decline in the NAA resonance, reflecting tempo-
rary neuronal injury, was only detected in the frontal cor-
tex. On the other hand, changes in Cho and MI were
similar across brain regions. The Cr resonance appeared
stable in all regions and times with the exception of white
matter where a transient increase was observed at peak
viremia.
Evidence of neuronal injury is detected only in the frontal 
cortex
A decrease in NAA is only observed in the frontal cortex at
2 wpi, the time of peak viremia. NAA is almost exclusively
located in neurons, and a decrease in NAA reflects neuro-
nal loss [22,23] or reversible neuronal injury [24,25].
Lentz et al. showed that encephalitis severity correlates
with decreased NAA/Cr levels in the frontal cortex in the
macaque model of neuroAIDS [26,27]. With the reduc-
tion of SIV plasma viral load by 1–2 orders of magnitude
at 4 wpi, NAA levels are also no longer abnormal, suggest-
ing that partial immunologic control of the virus is suffi-
cient to result in neuronal recovery. The selective neuronal
vulnerability of frontal cortex to SIV infection is further
supported by the observation of significant decreases in
synaptophysin (SYN) in the frontal cortex but not in the
basal ganglia (unpublished results). SYN is an integral
membrane glycoprotein in presynaptic vesicles. Its decline
indicates a disruption in synaptic transmission and it is
therefore a sensitive marker of neuronal dysfunction. We
have previously shown that SYN is highly correlated to in
vivo  NAA/Cr measurements in this same SIV/macaque
model of neuroAIDS [24].
Choline changes in the same manner in the brain regions
The Cho levels appear to change in a similar fashion in all
brain regions after SIV infection. This implies that the
changes are global, and not specific to any particular brain
region. MI increased significantly in the FC and WM, and
MI changes correlated between frontal cortex and basal
ganglia (P = 0.043, Rs = 0.37), but not between white matter
and the other two regions. It must be noted that when the
correlations are subjected to Bonferroni correction, the MI
correlations lose significance, however, the choline correla-
Table 2: Spearman Rank correlation analyses of metabolite concentrations between different brain regions of the SIV infected 
macaques.
NAA Glx Cr Cho MI
Spearman Rank Rs pR s PR s pR s pR s p
FC – WM NS 0.32 0.088 NS 0.52 0.0032 NS
FC – BG NS 0.52 0.0034 NS 0.36 0.052 0.37 0.043
WM – BG 0.50 0.0049 NS NS 0.54 0.0021 NS
For this purpose the percent change from baseline were calculated for each individual monkey for all time points. Significant P-values are noted in 
bold. P-values with a trend towards significance (P < 0.1) are noted italics and non-significant differences are indicated by NS. However, it must be 
noted that when the correlations are subjected to Bonferroni correction, a P-value of < 0.0033 is required for significance.BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
Page 7 of 12
(page number not for citation purposes)
tions between the regions remain significant after Bonfer-
roni correction. At the time of peak viremia, Cho levels are
elevated, and they decrease to baseline levels or lower with
a reduction of plasma viral load at 4 wpi. An increase in
Cho may reflect altered membrane metabolism [28], and
may be associated with cerebral inflammation. Its elevation
is believed to reflect cellular responses, including cell pro-
liferation, recruitment, microgliosis, and/or astrocytosis in
neuroAIDS [29,30]. Evidence of the association with astro-
cytosis is given by our observations of elevated GFAP at the
same time point in this model [31].
In a previous report [15] we reported that Cho levels in
the frontal cortex decreased to levels significantly below
baseline by 4 wpi. In extending our analyses to other
regions we find that at 4 wpi Cho levels are below baseline
in the white matter and basal ganglia, but these are not
significant. However, significant declines in Cho were
observed in all 3 regions between 2 and 4 wpi, a period
when viral loads are substantially reduced. The best inter-
pretation of this observation is that it is a manifestation of
brain recovery and healing.
Cerebral MI increased almost linearly after SIV infection.
MI is located primarily in glia; thus, elevation of MI is con-
sidered to reflect increased glial cell activity [32]. An eleva-
tion of MI has been commonly reported in studies of
chronically infected HIV patients [9,16]. The increases in
MI were not as highly correlated between the brain
regions, but they appeared to increase in all 3 regions
almost linearly up to 4 wpi. We have previously reported
that there is a complex relationship between astrocytosis
and MI, as well as between astrocytosis and Cho [31]. The
data reported here on Cho and MI continue to support a
complex relationship among these measurements that
occur when the animal is infected. Further studies are nec-
essary to elucidate the relationships.
Creatine increases during acute SIV infection in white 
matter
At the time of peak viremia, Cr concentrations were signif-
icantly increased in the white matter of the centrum sem-
iovale. Changes in total Cr (phosphocreatine and
creatine) are associated with altered energy metabolism.
Elevated Cr levels have been reported in the frontal white
matter of chronic HIV patients [33]. It is believed that the
virus enters the brain through infected monocytes that
later differentiate into macrophages [34,35]. During this
process of mononuclear cell infiltration, glial-cell activa-
tion and proliferation may manifest high tissue metabo-
lism which would explain an increase in Cr. Energy
change as a function of enhanced glial activation is sup-
ported by our finding that the greatest increases in MI and
Cho are in the same regions as the highest increase in Cr
(Figure 2). Our finding that creatine changes are not uni-
form across the brain regions is consistent with the study
by Chang et al. [33] who reported creatine increases in the
white matter but decreases in the basal ganglia in later
stages of AIDS dementia complex.
Comparison of HIV and SIV
Most HIV MRS studies are performed during the chronic
stage of infection, often with subjects who are on antiret-
roviral therapy. Our macaque study focuses on acute SIV
infection, a period that has not yet been studied by MRS
in HIV infection. Acute SIV infection induces the most
profound NAA changes in the frontal cortex, and more
subtle and difficult to detect changes in the basal ganglia
and white matter. We hypothesize that HIV in humans
might produce similar responses during the primary infec-
tion as those described here. During primary infection,
HIV and SIV proliferate to very high levels for a short time.
As the immune system responds to the infection, plasma
virus drops to lower levels. There may be recurrence of
high viremia with the progressive weakening of the
immune system by the virus. Anti-retroviral therapy will
suppress viral production at this stage. It is only at the last
stage, with the collapse of the immune system, that very
high viremia is once again observed. There are very few
reported MRS studies of people with early [17] or late high
viremia [36,37]. It is possible that the difference in viral
loads in patients is the most important factor responsible
for differences MRS patterns that have been reported.
The macaque model has similar MR spectroscopic
changes (diminished NAA, elevated Cho and MI) as in
human neuroAIDS, suggesting that neurochemical and
cellular responses to SIV and HIV are similar. However,
the specific pattern of MRS changes in various brain
regions of the acutely SIV-infected macaque appears dif-
ferent from that seen in humans. Both, single voxel MRS
and magnetic resonance spectroscopic imaging (MRSI)
studies performed before the advent of anti-retroviral
therapy demonstrated profound declines in the levels of
NAA in advanced cognitively impaired patients
[29,38,39]. In the early stages of cognitive dysfunction,
Cho/Cr and MI/Cr were shown to be elevated prior to
changes in NAA [40].
More recently in the anti-retroviral era, in vivo 1H MRS
studies of HIV patients have consistently found metabolic
abnormalities in different brain regions [5,6]. Some
groups have reported that the most profound MRS
changes occur in the basal ganglia and white matter [7,8].
Others have reported significant changes in the frontal
cortex of HIV patients, even in patients free of neurologi-
cal symptoms [9]. Additionally, recent high spatial resolu-
tion neuroimaging investigations using sophisticated
analytic methods have found diminution in the thickness
of the cortical mantle [41].BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
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In this study we found region specific responses with
respect to NAA but not choline. MRSI studies investigating
the regional metabolic responses in HIV infected patients
with HIV associated dementia were found to be quite var-
iable. Some report evidence of uniform metabolic abnor-
malities (decreased NAA/Cr [39] and increased Cho/Cr)
in various brain regions and conclude that abnormalities
of cerebral metabolites in HIV-infected patients may be
part of a diffuse process [42]. However, some MRSI stud-
ies observe NAA/Cr decreases [16] and Cho/Cr increases
[43] in gray matter regions and not in white matter in
patients with AIDS dementia complex. Additionally,
Barker et al. reported that the largest reductions in NAA
and increases in Cho were in the frontal lobe white matter
and there were no changes in the cortical gray matter [38].
This great variability could be the result of many factors
including: disease stage; the presence, type and duration
of antiretroviral treatment; co-morbidities including drug
abuse; and differences in imaging parameters such as
pulse sequence, TE and TR.
We also investigated potential correlations between
plasma viral load and metabolite concentration changes.
We previously reported [15] a significant relationship
between changes in Cho/Cr and plasma viral loads (Rs =
0.79, P < 0.01) by Spearman Rank correlation analyses.
Here, we found a correlation between plasma viral loads
and Cho/Cr changes in the basal ganglia and Cho changes
in BG. There was no relationship between WM Cho
changes and plasma viral loads or between any of the
other metabolite concentrations/ratios and viral loads.
These preliminary findings are different from what has
been reported for patients with HIV, however, our study
focuses on the acute phase of infection, unlike human
studies which involve chronically infected individuals.
Among HIV+ patients higher plasma viral loads are typi-
cally associated with lower NAA [44] and higher MI [33].
Another study reported that CSF but not plasma viral load
correlated with Cho/Cr in the white matter [45]. Again,
there are many potential reasons for differences in corre-
lations that have been reported between viral loads and
MRS metabolites.
Possible mechanisms of regional brain metabolic 
abnormalities
The leading theory of neuroAIDS pathogenesis is that
infected/activated monocytes traffic into the CNS, where
they differentiate into macrophages, and set off a cascade
of events that ultimately result in neuronal injury [46].
One possibility that may explain regional variations in
brain injury is that there are differences in the rate of
monocyte trafficking into various brain regions. However,
the similarity in the changes in Cho and MI observed in
all regions suggests that the trafficking is globally similar.
This is supported by the finding of similar astrocytic acti-
vation in frontal cortex and basal ganglia (unpublished
results). However, while the evidence suggests that viral
invasion is globally similar, neuronal injury is selective to
the frontal cortex. Cortical neurons may be more suscep-
tible to injury or neuronal protective/recovery mecha-
nisms may be more effective in other regions.
The relationship of brain metabolic changes with respect
to the level of virus in the blood is important. The greatest
changes in NAA, Cho and Cr occur at the time of peak
viremia followed by near normalization within 2 weeks.
This sensitivity of the brain to events in the blood indi-
cates a highly dynamic pathogenic process with the rapid
transit of virally-infected monocytes into the brain and an
equally rapid response by the brain to these events. The
highly dynamic nature is further supported by the rapid
normalization as plasma viral load decreases. Notably,
this normalization occurs despite persistent virus in the
blood, although not at peak levels. This observation sug-
gests there may be a competition between pathogenic and
protective mechanisms, and that a threshold level of viral
load and trafficking, virally-infected monocytes must be
exceeded for brain metabolic response to be manifested.
Patient Management
Our results imply that the virus has a global effect on
microgliosis and astrogliosis. However, only cortical
regions, here the frontal cortex, are affected by neuronal
injury, suggesting that some regions of the brain are more
vulnerable to invasion by SIV or HIV infected macro-
phages. These results may support the use of a combina-
tion of antiretroviral therapy early to decrease influx of
infected/activated monocytes/macrophages that lead to
inflammation and neuroprotective drugs which pass the
BBB in order to prevent neuronal injury in region of the
brain in which the innate recovery mechanisms fail.
MR spectroscopy should be considered for use in clinical
HIV patient care to monitor changes in metabolism indic-
ative of neuronal dysfunction possibly predictive of cogni-
tive dysfunction. Single voxel MRS [29,33,47] as well as
magnetic resonance spectroscopic imaging (MRSI)
[16,30,36,38,39,42,43,48,49] have been performed on
patients with HIV dementia. Single voxel MRS has been
commonly used since it is a shorter scan (for one voxel
location) and requires less data processing. However,
MRSI is a much more efficient technique to record MR
spectroscopy data since it examines multiple regions in
one data acquisition. Both techniques have shown signif-
icant changes in metabolite concentration in individuals
with neuroAIDS and offer complementary information
and should be used in conjunction as suggested by Sack-
tor [43] if time allows.
Conclusion
In summary, during acute SIV infection, changes in Cho
and MI were similar across brain regions while a signifi-BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
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cant decrease in NAA, a marker of neuronal injury, was
found in the frontal cortex only. A potential mechanism
for these observations is that trafficking of infected mono-
cytes involves all brain regions producing cellular changes
(astrocytosis, microgliosis) that are reflected in elevations
in Cho and MI. However, the data suggest that there is var-
iable regional susceptibility to neuronal injury. With
respect to clinical HIV patient management, the data from
this model suggests that while the virus has global effects
such as astrogliosis, cortical regions may be more suscep-
tible to neuronal injury and merit observation, perhaps
with the inclusion of clinical MRS studies. Moreover, the
use of neuroprotective agents may be particularly useful in
the protection of cortical neuronal integrity. The SIV-
infected macaque model monitored with 1H MRS is an
excellent tool to further delineate the precise neuropatho-
genic mechanisms and to help assess the value of drugs
that may used as adjunctive therapy whose purpose is the
maintenance of cognitive normality.
Methods
Animals
The animals were housed according to the standards of
the American Association for Accreditation of Laboratory
Animal Care. Investigators adhered to the Guide for the
Care and Use of Laboratory Animals of the Institute of
Laboratory Animal Resources, National Research Council.
The study was approved by the Massachusetts General
Hospital Subcommittee on Research Animal Care and the
Institutional Animal Care and Use Committee of Harvard
University. Eighteen juvenile rhesus macaques (Macaca
mulatta) of both sexes were included in the in vivo MRS
study. All 18 animals had MR scans prior to infection with
SIVmac251 (50 ng p27/kg) [50]. A second MR scan was
obtained at 2 weeks post infection (wpi). Twelve of the
eighteen animals underwent a third MR examination at 4
wpi. This imaging schedule was adopted because acutely
infected macaques are unable to tolerate more frequent
scanning. Animals were housed at the New England
Regional Primate Research Center and transported to the
Massachusetts General Hospital/A.A. Martinos Center for
Biomedical Imaging. For imaging, the animals were tran-
quilized with ketamine or telazol and anesthetized with
sodium pentobarbital. Six of these animals were sacrificed
during the acute SIV infection for postmortem studies (ex
vivo MR spectroscopy and quantitative neuropathologic
analysis) the day after they underwent their last MR exam-
ination [24,31]. Eight of the remaining 12 animals were
also included in the previously reported longitudinal in
vivo 1H MR spectroscopy study [19].
MRI and MRS Studies
Both MRI and 1H MRS were performed using a standard
GE linear extremity coil on a clinical 1.5 Tesla General
Electric (Milwaukee, Wisconsin) Signa Scanner with an
operating system of Horizon 8.3. First, a three-plane local-
izer was performed to position the monkey in the coil. In
this manner, voxel placement was highly reproducible. A
sagittal T1-weighted image sequence (TE/TR = 20/600)
was utilized, followed by an axial dual echo pulse
sequence (TE(1) = 30 ms; TE(2) = 80 ms; TR = 2500 ms)
consisting of proton-weighted and T2-weighted images
from which the 1H MRS voxels were prescribed. With the
exception of a slightly smaller voxel size, the MRS proto-
col was identical to the one employed in multicenter
human HIV studies [5]. MRS was performed on each ani-
mal in frontal cortical gray matter, white matter semiovale
and putamen using a voxel size of 15 mm × 15 mm × 15
mm (3.4 cm3) (Figure 1). Data were acquired using an
automated PROBE-P spectroscopy package [51], which
consists of a PRESS sequence (TE = 35 ms, TR = 3000 ms,
number of acquisitions = 128) [52] with CHESS water
suppression [53].
All spectra were processed offline using the LCModel soft-
ware package [54] to determine the quantities of the brain
metabolites N-acetylaspartate and N-acetylaspartylgluta-
mate (collectively referred to as NAA), choline-containing
compounds (referred to as Cho), MI, creatine-containing
compounds (referred to as Cr) and the so-called Glx con-
centration (while glutamate and glutamine represent the
largest contributors to this peak area, we are aware that at
1.5T field strengths Glx will also include resonances from
GABA, NAA, aspartate, and possibly succinate). Metabo-
lite concentrations were estimated using the unsuppressed
water signal from the same voxel, which served as the
internal standard [55]. Absolute concentrations given by
LCModel are normalizations of each resonance to the
water peak, resulting in institutional units. Only if the tis-
sue water concentration and T1 and T2 relaxation effects
were estimated correctly, these units reflect a millimolar
concentration. Metabolite ratios with respect to creatine
were also calculated.
It is possible that alterations in metabolite transverse (T2)
relaxation times are responsible for changes in metabolite
resonance signals [56]. That is unlikely in the experiments
reported here for several reasons. First, during the first
month of SIV infection, we did not observe any signal
changes on the anatomic T2 weighted images in these
macaque brains suggesting little if any T2 effects. Addi-
tionally, some signal intensities increase at the same time
that others decrease. If T2 changes were responsible, then
some metabolites would be experiencing a prolongation
in the transverse relaxation time while it would be short-
ened in others, a highly unlikely scenario. Moreover, we
have previously reported high correlations between in vivo
NAA measurements and post mortem tissue extract levels of
this metabolite. The ex vivo measurements are made using
a single pulse, long TR method thus eliminating T2 effects.BMC Neuroscience 2009, 10:63 http://www.biomedcentral.com/1471-2202/10/63
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Viral loads
After the MRI/MRS examination, blood samples were
drawn from each animal to determine viral loads. Virion-
associated SIV RNA in plasma was measured by using a
real-time reverse transcription-PCR assay on an Applied
Biosystems (Foster City, CA) Prism 7700 sequence detec-
tion system as described previously [57,58]. Results are
averages of duplicate determinations.
Statistical Methods
The preinfection values of each metabolite were different
in the three brain regions. Thus for clarity, the data were
normalized by setting the average preinfection metabolite
concentration to 100 percent. Data taken at subsequent
time points were normalized by multiplying by the same
proportionality factor specific to brain region and metab-
olite. To test our hypothesis that all major cerebral metab-
olites are changing with time after SIV infection in a
region-dependent manner, a multivariate analysis of vari-
ance (MANOVA) was performed with respect to metabo-
lite, time post infection and brain region. Post hoc
repeated measures analyses of variance (RM ANOVAs) for
individual metabolites across time and region were car-
ried out only if the MANOVA was significant (p < 0.05).
MRS studies of uninfected macaques demonstrated that
the standard deviation between scans of the same animal
at different times was much smaller than the standard
deviation between animals [18]. Statistical analyses of
metabolite concentrations and metabolite ratios were per-
formed using RM ANOVA on the data from the 12 ani-
mals that were scanned before infection, at 2 and 4 weeks
after infection. If significant by RM ANOVA, Holm's t-
tests, which correct for multiple comparisons, were used
to isolate significant differences between time points.
For the 18 animals scanned at 0 and 2 wpi, paired t-tests
were used to compare preinfection scans to the 2 week pi
scans. A p-value of less than 0.05 was considered signifi-
cant. To assess interrelationships between metabolites in
the three brain regions, Spearman Rank correlation coeffi-
cients were used to assess potential associations between
regions for each metabolic marker. Again, a P-value of less
than 0.05 was considered to indicate a statistically signifi-
cant correlation. However, it must be noted that when the
correlations are subjected to Bonferroni correction (five
metabolites and 3 regions), a P-value of < 0.0033 is
required for significance. Additionally, potential relation-
ships between plasma viral loads and brain metabolite
changes at 2 and 4 weeks combined were assessed using
Spearman Rank correlations. Finally, a power calculation
was performed based on metabolite concentrations
acquired from four animals that were scanned £  4 times
pre inoculation over a period of 2 years. We found the
highest reproducibility in Cr > Glx > NAA > MI > Cho. The
minimum detectable difference was between 5 and 16%
for the metabolites with 80% power and a 5% significance
level, in 18 animals.
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